A detailed history of Citigroup Inc transactions in Dexcom Inc stock. As of the latest transaction made, Citigroup Inc holds 922,732 shares of DXCM stock, worth $70 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
922,732
Previous 635,498 45.2%
Holding current value
$70 Million
Previous $72.1 Million 14.17%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $18.4 Million - $33.3 Million
287,234 Added 45.2%
922,732 $61.8 Million
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $13 Million - $16.5 Million
-117,444 Reduced 15.6%
635,498 $72.1 Million
Q1 2024

May 10, 2024

SELL
$114.22 - $140.1 $13.8 Million - $16.9 Million
-120,628 Reduced 13.81%
752,942 $104 Million
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $30.5 Million - $50.2 Million
404,266 Added 86.14%
873,570 $108 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $8.69 Million - $13.9 Million
-101,009 Reduced 17.71%
469,304 $43.8 Million
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $4.3 Million - $5.01 Million
-38,223 Reduced 6.28%
570,313 $73.3 Million
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $27 Million - $31.9 Million
-259,520 Reduced 29.9%
608,536 $70.7 Million
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $10.2 Million - $14.8 Million
120,283 Added 16.09%
868,056 $98.3 Million
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $16.6 Million - $20.5 Million
217,402 Added 40.99%
747,773 $60.2 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $24.4 Million - $47.7 Million
359,159 Added 209.77%
530,371 $39.5 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $163,605 - $226,417
-1,739 Reduced 1.01%
171,212 $87.6 Million
Q4 2021

Feb 10, 2022

SELL
$129.87 - $162.82 $2.92 Million - $3.66 Million
-22,484 Reduced 11.5%
172,951 $92.9 Million
Q3 2021

Nov 10, 2021

BUY
$106.71 - $143.18 $20.9 Million - $28 Million
195,435 New
195,435 $107 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.